ArticleMolecular biomedicine2026

Structurally-optimised HPV16 E7/E6 mRNA-LPP mediates dose-sparing efficacy via tumour microenvironment reprogramming.

Shucai Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.